The Argentina Latin America Advanced Wound Care Market was valued at $9.44 Million in 2025 and projected to reach to $15.04 Million by 2030, representing a compound annual growth rate of 9.8%. Argentina's advanced wound care market is positioned for steady growth driven by demographic shifts, rising diabetes prevalence, and aging population segments requiring specialized wound management.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Argentina's advanced wound care market is valued at $9.44 million in 2025, with a projected CAGR of 9.8% through 2030, reaching $15.04 million by forecast end.
Rising incidence of diabetic ulcers and pressure injuries in Argentina is driving demand for advanced wound care solutions, supported by increasing healthcare awareness.
Argentina's healthcare system is modernizing with enhanced investment in wound care technologies and clinical capabilities to address chronic disease management.
Increased government and private sector healthcare expenditure in Argentina is facilitating adoption of advanced wound care products and treatment protocols.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SILICON DRESSINGS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.8% from 2025 to 2030 |
| Largest Segment | CHRONIC WOUNDS (Wound Type) |
| Market Size Base Year (Billions) | ~USD 0.31 (2025) |
| Revenue Forecast (Billions) | ~USD 0.5 (2030) |
| Segments Covered | Product, Type, Wound Type, End User |
4 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 6.83 | 7.5 | 8.24 | 9.07 | 9.98 | 12.13 | 13.39 | 14.84 | 10.4 |
| HOME CARE SETTINGS | 2.33 | 2.49 | 2.68 | 2.88 | 3.1 | 3.6 | 3.88 | 4.2 | 7.8 |
| HOSPITALS & CLINICS | 8.59 | 9.35 | 10.19 | 11.1 | 12.11 | 14.45 | 15.79 | 17.32 | 9.3 |
| OTHER END USERS | 5.45 | 5.87 | 6.33 | 6.84 | 7.38 | 8.64 | 9.36 | 10.17 | 8.3 |
| TOTAL | 23.2 | 25.22 | 27.45 | 29.89 | 32.58 | 38.81 | 42.42 | 46.54 | 9.3 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| SOLVENTUM | United States | Public Company | Foam dressings,Hydrocolloid dressings,Film dressings, |
| MöLNLYCKE AB | Sweden | Private Company | Foam dressings,Hydrocolloid dressings,Film dressings, |
| COLOPLAST GROUP | Denmark | InvalidIdentifier | Foam,Hydrocolloid,Film, |
| SMITH+NEPHEW | United Kingdom | Public Company | Foam,Hydrocolloid,Film, |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Foam dressings,Hydrocolloid dressings,Alginate dressings, |
| CARDINAL HEALTH | United States | Public Company | Foam dressings,Film dressings,Hydrocolloid dressings, |
| ESSITY AKTIEBOLAG | Sweden | Public Company | Foam dressings,Hydrocolloid dressings,Film dressings, |
| PAUL HARTMANN AG | Germany | Public Company | Foam dressings,Hydrocolloid dressings,Film dressings, |
| INTEGRA LIFESCIENCES CORPORATION | United States | Public Company | Collagen,Foam,Hydrocolloid, |
| MATIV HOLDINGS, INC. | United States | Public Company | Foam-associated materials (backings, adhesives, films),Film dressings and components,Hydrocolloid-associated substrates, |
| OWENS & MINOR | United States | Public Company | Foam dressings,Hydrocolloid dressings,Film dressings, |
| AVERY DENNISON CORPORATION | United States | Public Company | Foam dressings (adhesive layers, backing films, labels),Film dressings and IV securement (films, coatings, printing),Hydrocolloid dressings (adhesive components, labeling), |
Solventum is a publicly traded United States company founded in 2023 with 20,584 employees.
Mölnlycke AB is a private Swedish company established in 1849 with 8,463 employees.
Coloplast Group is a Danish company with insufficient data available for a complete description.
Smith+Nephew is a publicly traded United Kingdom company founded in 1856 with 16,988 employees.
ConvaTec Group PLC is a publicly traded United Kingdom company founded in 1978 with 10,910 employees.
Cardinal Health is a publicly traded United States company founded in 1979 with 55,392 employees.
Essity Aktiebolag is a publicly traded Swedish company founded in 1849 with 36,000 employees.
Paul Hartmann AG is a publicly traded German company established in 1818 with 10,066 employees.
Integra LifeSciences Corporation is a publicly traded United States company founded in 1989 with 4,427 employees.
Mativ Holdings, Inc. is a publicly traded United States company founded in 1995 with 5,000 employees.
Owens & Minor is a publicly traded United States company established in 1882 with 6,500 employees.
Avery Dennison Corporation is a publicly traded United States company founded in 1935 with 35,000 employees.
Argentina's advanced wound care market was valued at $9.44 million in 2025 and is projected to reach $15.04 million by 2030.
Argentina's advanced wound care market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2030.
Key drivers include Argentina's aging demographic, rising prevalence of chronic wounds and diabetes, improving healthcare infrastructure, and increasing adoption of advanced wound management technologies.
Argentina is seeing increased adoption of bioactive dressings, negative pressure wound therapy systems, antimicrobial wound care solutions, and other advanced wound management products.
Argentina is a key market within Latin America's advanced wound care sector, with growth dynamics aligned to the regional 9.8% CAGR, reflecting strong healthcare investment and clinical adoption trends.
This study involved the extensive use of both primary & secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the LATAM advanced wound care market. The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the LATAM advanced wound care market. All the major service providers were identified at the country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the LATAM advanced wound care market was split into various segments and subsegments based on:
The above data was consolidated and added with detailed input and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the LATAM advanced wound care market through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Advanced wound care involves the utilization of advanced dressings such as foam dressings, hydrocolloid dressings, film dressings, and alginate dressings to facilitate the rapid healing & management of wounds such as chronic ulcers, diabetic foot ulcers, burns, traumatic wounds, and surgical wounds. The adoption of advanced wound care provides early & smooth healing, efficient treatment, and cost-effectiveness to end users.
Full forecast, segment splits, and company analysis for all Latin America Advanced Wound Care Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report